An urgent call to publish COVID-19 trials: a systematic search revealed ZERO studies regarding the incidence of thromboembolic events in SARS-CoV-2 Omicron-infected COVID-19 patients
Authors' conclusion
There is currently no high-quality evidence on the incidence of thromboembolic events in Omicron-infected COVID-19 patients.
Study context
- Population
- COVID-19 patients infected with SARS-CoV-2 Omicron variantsno study included
- Outcome
- Thromboembolic events, objective diagnostic criteria
- Follow-up
- Within 28 days of infection
Methodological detailsindependent screening by two reviewers, Cochrane COVID-19 Study Register searched, studies published November 30, 2021, to January 31, 2024
- Independent screening by two reviewers
- Cochrane COVID-19 Study Register searched, studies published November 30, 2021, to January 31, 2024
Pooled result
As reported in the abstract
Full-text screening
238
Original publication
An urgent call to publish COVID-19 trials: a systematic search revealed ZERO studies regarding the incidence of thromboembolic events in SARS-CoV-2 Omicron-infected COVID-19 patients. Crit Care. Published 1 May 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →